Central Bank & Trust’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-35,765
Closed -$3.55M 299
2019
Q3
$3.55M Sell
35,765
-11,372
-24% -$1.08M 0.76% 43
2019
Q2
$4.36M Sell
47,137
-9,902
-17% -$940K 0.98% 39
2019
Q1
$5.38M Sell
57,039
-2,976
-5% -$260K 1.21% 28
2018
Q4
$3.85M Sell
60,015
-629
-1% -$46.4K 0.97% 33
2018
Q3
$5.43M Sell
60,644
-4,903
-7% -$433K 1.26% 28
2018
Q2
$5.21M Buy
65,547
+7,494
+13% +$622K 1.3% 28
2018
Q1
$5.18M Sell
58,053
-561
-1% -$53.9K 1.29% 27
2017
Q4
$6.12M Sell
58,614
-1,855
-3% -$209K 1.48% 18
2017
Q3
$8.82M Buy
60,469
+402
+0.7% +$54.8K 2.19% 6
2017
Q2
$7.8M Buy
60,067
+57
+0.1% +$6.98K 2.03% 9
2017
Q1
$7.47M Sell
60,010
-2,322
-4% -$278K 1.93% 11
2016
Q4
$7.21M Sell
62,332
-19,789
-24% -$2.2M 1.93% 11
2016
Q3
$8.58M Sell
82,121
-5,752
-7% -$623K 2.41% 4
2016
Q2
$8.67M Buy
87,873
+4,628
+6% +$479K 2.49% 3
2016
Q1
$8.33M Sell
83,245
-3,669
-4% -$378K 2.33% 7
2015
Q4
$10.4M Sell
86,914
-159
-0.2% -$18.4K 3.01% 5
2015
Q3
$9.42M Buy
87,073
+2,072
+2% +$257K 3.11% 5
2015
Q2
$9.84M Buy
85,001
+1,255
+1% +$143K 3.13% 5
2015
Q1
$9.65M Buy
83,746
+1,619
+2% +$193K 3.21% 4
2014
Q4
$9.19M Sell
82,127
-1,728
-2% -$182K 3.15% 2
2014
Q3
$7.95M Buy
83,855
+41,762
+99% +$3.77M 3.01% 2
2014
Q2
$7.11M Sell
42,093
-42,685
-50% -$3.25M 2.75% 3
2014
Q1
$5.92M Buy
84,778
+592
+0.7% +$46.9K 2.31% 4
2013
Q4
$7.11M Buy
84,186
+104
+0.1% +$8.23K 2.75% 3
2013
Q3
$6.48M Sell
84,082
-3,778
-4% -$265K 2.9% 2
2013
Q2
$5.14M Buy
+87,860
New +$5.29M 2.44% 3

Other funds holding CELG

Central Bank & Trust's CELG Position: Q4 2019 in Review

Central Bank & Trust sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 35,765 shares — an estimated $3.55M sold.

Central Bank & Trust first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $10.4M in Q4 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Central Bank & Trust reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Central Bank & Trust sold 35,765 Celgene Corp shares in Q4 2019, an estimated $3.55M.
  • Central Bank & Trust first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Central Bank & Trust's Celgene Corp position peaked at $10.4M in Q4 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Central Bank & Trust's 13F filing for Q4 2019, filed 13 Jan 2020.